The Tyr-kinase inhibitor AG879, that blocks the ETK-PAK1 interaction, suppresses the RAS-induced PAK1 activation and malignant transformation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples